Inactive Instrument

Highlights Ossen Innovation Co., Ltd.

Equities

OSN

US6884102087

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Ossen Innovation : Announces Completion of Merger (Form 6-K)	21-09-13	PU
Pujiang International : Closes $11.5 Million Privatization of Nasdaq-listed Unit	21-09-13	MT
Ossen Innovation : Announces Completion of Merger	21-09-09	PR
Pujiang International Group Limited completed the acquisition of remaining 34.1% stake in Ossen Innovation Co., Ltd..	21-09-08	CI
Ossen Innovation : Amends Merger, Going Private Deal Agreement to Extend Termination Date	21-06-16	MT
Ossen Innovation : Enters into Amendment No. 1 to Merger Agreement for Going Private Transaction (Form 6-K)	21-06-16	PU
Ossen Innovation : Enters into Amendment No. 1 to Merger Agreement for Going Private Transaction	21-06-16	PR
Ossen Innovation Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-17	CI
Ossen Innovation Co., Ltd. Provides Revenue Guidance for the Full Year 2020	21-03-17	CI
Ossen Innovation : to Go Private Through Merger With New Ossen Group; Shares Rise	20-12-17	MT
Pujiang International Group Limited entered into a preliminary non-binding proposal to acquire remaining 34.1% stake in Ossen Innovation Co., Ltd. for $11.5 million.	20-09-15	CI
Ossen Innovation Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-27	CI
Ossen Innovation Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-19	CI
Ossen Innovation Co., Ltd. Provides Financial Guidance for the Full Year 2019	20-03-23	CI
Ossen Innovation Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-27	CI
Ossen Innovation Co., Ltd. Announces Consolidated Earnings Results for the Year Ended December 31, 2018	19-05-14	CI
Ossen Innovation Co., Ltd. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018	18-09-20	CI
Ossen Innovation Co., Ltd. Announces Earnings Results for the Full Year Ended December 31, 2017	18-05-16	CI
America-Asia Diabetes Research Foundation cancelled the acquisition of Ossen Innovation Co., Ltd. from Liang Tang and other shareholders in a reverse merger transaction.	18-05-07	CI
Liang Tang cancelled the acquisition of Ossen Innovation Materials Group Co., Ltd. from Ossen Innovation Co., Ltd..	18-05-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Ossen Innovation Co., Ltd.

Equities

OSN

US6884102087

Highlights

Filters